CCCC — C4 THERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 156 家机构在其最新 13F 申报中持有 CCCC(C4 THERAPEUTICS INC),合计申报市值 $498.11M,对应 107.17M 股。按股数计算较上季度增持 17.2%(+13.35M 股),申报市值环比上升 108.1%。持仓集中度较高:前五大持有人占申报市值的 36.8%,前十大的集中度为 55.0%。
与上一季度相比,55 家新建仓位、55 家加仓、31 家减仓、26 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
C4 THERAPEUTICS INC(CCCC)的主要机构持有人包括 RA CAPITAL MANAGEMENT, L.P.、Lynx1 Capital Management LP、Bain Capital Life Sciences Investors, LLC,按 13F 申报市值在本页 302 家持有人中排名居前。
CCCC 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 90 | 59.99M | $198.86M | +19.4% |
| Q2 2026 | 156 | 107.17M | $498.11M | +17.2% |
| Q1 2026 | 127 | 80.14M | $209.68M | -2.1% |
| Q4 2025 | 104 | 77.98M | $148.92M | +19.6% |
| Q3 2025 | 98 | 51.89M | $115.17M | -10.0% |
| Q2 2025 | 103 | 55.88M | $79.89M | -6.3% |
| Q1 2025 | 119 | 64.63M | $103.34M | +14.4% |
| Q4 2024 | 118 | 60.83M | $218.76M | +3.8% |
表内 8 个季度中,机构持股合计减少 1%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2025(+19.6%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 9.44M | $18.03M | 0.07% | 新进 | |
| 8.98M | $17.15M | 0.00% | 增持 | |
| 8.00M | $15.28M | 0.16% | 新进 | |
| 7.17M | $13.70M | 1.05% | 增持 | |
| 7.10M | $13.56M | 2.74% | 持有 | |
| 4.38M | $8.37M | 0.00% | 增持 | |
| 4.34M | $8.30M | 0.05% | 减持 | |
| 3.80M | $7.27M | 0.27% | 减持 | |
| 2.39M | $4.56M | 0.00% | 增持 | |
| 1.99M | $3.81M | 0.58% | 增持 | |
| 1.97M | $3.76M | 0.00% | 增持 | |
| 1.60M | $3.06M | 0.01% | 增持 | |
| 1.51M | $2.88M | 0.01% | 增持 | |
| 1.40M | $2.68M | 0.06% | 减持 | |
| 1.19M | $2.27M | 0.00% | 减持 | |
| 1.19M | $2.27M | 0.00% | 增持 | |
| 1.09M | $2.08M | 0.00% | 增持 | |
| 1.07M | $2.04M | 0.00% | 增持 | |
| 988.88K | $1.89M | 0.00% | 增持 | |
| 874.79K | $1.67M | 0.00% | 增持 | |
| 809.26K | $1.55M | 0.00% | 增持 | |
| 449.43K | $858.41K | 0.00% | 增持 | |
| 449.43K | $858.41K | 0.00% | 增持 | |
| 400.00K | $764.00K | 0.04% | 新进 | |
| 342.77K | $654.70K | 0.00% | 增持 |
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 7.42M | $10.62M | 0.06% | 增持 | |
| 7.10M | $10.15M | 2.93% | 持有 | |
| 6.98M | $9.98M | 0.66% | 持有 | |
| 6.83M | $9.77M | 0.26% | 持有 | |
| 4.75M | $6.80M | 0.00% | 增持 | |
| 3.02M | $4.32M | 0.00% | 减持 | |
| 2.01M | $2.87M | 0.00% | 增持 | |
| 1.83M | $2.61M | 0.00% | 减持 | |
| 1.11M | $1.59M | 0.20% | 持有 | |
| 1.10M | $1.57M | 0.00% | 增持 | |
| 1.10M | $1.57M | 0.00% | 增持 | |
| 1.09M | $1.56M | 0.00% | 增持 | |
| 900.00K | $1.29M | 0.07% | 持有 | |
| 880.26K | $1.26M | 0.00% | 增持 | |
| 811.40K | $1.16M | 0.00% | 增持 | |
| 745.05K | $1.07M | 0.00% | 减持 | |
| 683.60K | $977.55K | 0.00% | 增持 | |
| 572.03K | $818.00K | 0.00% | 减持 | |
| 492.61K | $704.43K | 0.00% | 增持 | |
| 441.74K | $631.68K | 0.00% | 减持 | |
| 431.89K | $617.48K | 0.00% | 减持 | |
| 383.79K | $548.82K | 0.00% | 增持 | |
| 383.79K | $548.82K | 0.00% | 增持 | |
| 331.90K | $474.61K | 0.00% | 减持 | |
| 331.90K | $474.61K | 0.00% | 减持 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 2.52M 股 · $11.78M
- Ikarian Capital, LLC 2.43M 股 · $11.36M
- Candriam S.C.A. 1.80M 股 · $8.38M
- Patient Square Capital LP 1.61M 股 · $7.51M
- HighVista Strategies LLC 1.35M 股 · $6.30M
- Sixth Street Partners Management Company, L.P. 781.06K 股 · $3.65M
- BOOTHBAY FUND MANAGEMENT, LLC 736.33K 股 · $3.44M
- VANGUARD PORTFOLIO MANAGEMENT LLC 680.09K 股 · $3.18M
- Velan Capital Investment Management LP 570.00K 股 · $2.66M
- Rockefeller Capital Management L.P. 495.82K 股 · $2.32M
- Nuveen, LLC 484.01K 股 · $2.26M
- ADAGE CAPITAL PARTNERS GP, L.L.C. 325.00K 股 · $1.52M
完全清仓(较上季)
- ORBIMED ADVISORS LLC 卖出 856.35K 股 · $2.25M
- STATE STREET CORP 卖出 382.97K 股 · $1.01M
- 683 Capital Management, LLC 卖出 300.00K 股 · $789.00K
- Hudson Bay Capital Management LP 卖出 130.08K 股 · $342.11K
- Mariner, LLC 卖出 127.52K 股 · $334.17K
- Verdad Advisers, LP 卖出 109.41K 股 · $287.74K
- Brevan Howard Capital Management LP 卖出 92.65K 股 · $243.66K
- OMERS ADMINISTRATION Corp 卖出 59.70K 股 · $157.01K
- READYSTATE ASSET MANAGEMENT LP 卖出 49.59K 股 · $130.41K
- Focus Partners Wealth 卖出 38.19K 股 · $100.43K
- Diametric Capital, LP 卖出 34.59K 股 · $90.98K
- Farallon Capital Management 卖出 28.00K 股 · $73.64K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley | 8.87M | 8.87M | 9.07M | 8.98M | 4.97M | 4.75M | 4.05M | 3.84M | 2.33M | 1.14M | 514.18K | 205.34K | 313.08K | 241.04K | 294.14K | 379.20K | 344.39K | 455.46K | 657.57K | 918.47K |
| BlackRock Inc | 8.18M | 7.90M | 2.05M | 1.97M | 1.60M | 1.83M | 5.28M | 5.56M | 4.89M | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.58M | 4.42M | 3.86M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 4.70M | 4.75M | 3.22M | 5.95K | 4.43K | 4.61K | 34.42K | 33.41K | 25.78K | 24.99K | 6 | 6.89K | 9.13K | 1.50K | 1.64K | 100.48K | 26.36K | 24.78K | 69.42K | 28.72K |
| WASATCH ADVISORS LP | 4.16M | 3.52M | 2.96M | 4.34M | 4.85M | 7.42M | 6.72M | 6.07M | 5.68M | 4.85M | 4.33M | 7.14M | 6.25M | — | — | — | — | — | — | — |
| SILVERARC CAPITAL MANAGEMENT, LLC | 3.45M | 3.03M | 1.91M | 1.99M | 1.90M | — | 882.30K | 1.22M | 150.00K | 150.00K | 150.00K | — | — | — | — | — | — | — | — | — |
| Candriam S.C.A. | 2.76M | 1.80M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 2.70M | 2.52M | 951.04K | 988.88K | 725.30K | 745.05K | 1.43M | 1.38M | 1.37M | 1.36M | 510.31K | 482.29K | 455.84K | 438.96K | 840.78K | 797.29K | 777.22K | 721.42K | 667.82K | 686.18K |
| Qube Research & Technologies Ltd | 2.40M | 370.55K | 752.11K | 290.23K | 115.97K | — | — | — | — | 258.43K | 388.19K | 27.09K | 6.89K | — | — | — | — | — | — | — |
| STATE STREET CORP | 2.22M | — | 382.97K | 342.77K | 287.37K | 287.37K | 1.22M | 1.22M | 2.81M | 2.99M | 7.15M | 155.37K | 155.37K | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 1.38M | 1.19M | 442.52K | 296.48K | 349.29K | 431.89K | 514.15K | 523.93K | 578.88K | 619.11K | 632.09K | 115.51K | 182.62K | — | — | — | — | — | — | — |
| CONGRESS ASSET MANAGEMENT CO | 1.26M | 1.00M | 830.62K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | 1.21M | 1.19M | 2.46M | 1.60M | 936.95K | 1.09M | 214.50K | — | — | 235.20K | 405.80K | 424.70K | 357.99K | 516.90K | 326.08K | 32.50K | 62.80K | 11.50K | — | 31.30K |
| Fidelity Management & Research (FMR) | 1.18M | 894.05K | 272.37K | 254.41K | 211.35K | 201.36K | 193.75K | 218.37K | 185.94K | 23.63K | 37.29K | 37.56K | 121.17K | 54.77K | 55.10K | 52.34K | 57.52K | 1.31K | 599.28K | 648.98K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.09M | 680.09K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HighVista Strategies LLC | 873.28K | 1.35M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Marshall Wace | 855.80K | 227.00K | 155.50K | 265.03K | 106.28K | — | — | 36.17K | 225.42K | — | 146.64K | 1.12M | — | — | 113.24K | — | — | 252.33K | — | — |
| VANGUARD FIDUCIARY TRUST CO | 721.74K | 609.15K | 484.13K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| PANAGORA ASSET MANAGEMENT INC | 690.69K | 264.95K | 86.76K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nuveen, LLC | 591.83K | 484.01K | — | — | — | — | 192.42K | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold CCCC?
As of 2026-Q2, 156 institutional funds reported holding CCCC (C4 THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $498.11M.
How many shares of CCCC do institutions own?
13F filers reported 107.17M shares of CCCC, worth $498.11M in aggregate at the end of 2026-Q2.
Is institutional ownership of CCCC rising or falling?
Share counts moved +17.2% versus the prior quarter — accumulation.
Who are the top institutional holders of CCCC?
The largest 13F holders are RA CAPITAL MANAGEMENT, L.P., Lynx1 Capital Management LP, Bain Capital Life Sciences Investors, LLC, Morgan Stanley, BlackRock Inc; the top 25 are ranked at the top of this page.
Who are the major shareholders of C4 THERAPEUTICS INC?
The major shareholders of C4 THERAPEUTICS INC (CCCC) by reported 13F value are RA CAPITAL MANAGEMENT, L.P., Lynx1 Capital Management LP, Bain Capital Life Sciences Investors, LLC, Morgan Stanley, BlackRock Inc, among 302 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.